Characterizing the hypertensive cardiovascular phenotype in the UK Biobank

Hussein Elghazaly1, Celeste McCracken2, Liliana Szabo3,4,5

  • 1Department of Surgery and Cancer, Imperial College London and Imperial College NHS Trust, South Kensington, SW7 2BX London, UK.

Insights

Hypertension causes adverse cardiovascular changes like thickened heart muscle and reduced heart function. These effects are less severe in individuals with well-controlled blood pressure.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Public Health

Background:

  • Hypertension is a major risk factor for cardiovascular disease.
  • Cardiovascular magnetic resonance (CMR) provides detailed insights into cardiac structure and function.
  • Understanding hypertension-related phenotypes is crucial for risk stratification and management.

Purpose of the Study:

  • To characterize hypertension-associated cardiovascular magnetic resonance (CMR) phenotypes.
  • To investigate variations in these phenotypes across diverse patient populations.
  • To assess the impact of blood pressure control on cardiovascular remodelling.

Main Methods:

  • Analysis of CMR data from 39,095 UK Biobank participants.
  • Hypertension status determined via health record linkage.
  • Multivariable regression models adjusted for vascular risk factors; stratified analyses by sex, ethnicity, and BP control.

Main Results:

  • Hypertension linked to concentric left ventricular (LV) hypertrophy, impaired LV function, and reduced aortic distensibility.
  • Significant differences observed in hypertension-related changes across sex and ethnicity.
  • Adverse cardiovascular remodelling was substantially attenuated in participants with good blood pressure control.

Conclusions:

  • Hypertension is associated with distinct CMR-defined cardiovascular remodelling patterns.
  • Sex and ethnicity influence the manifestation of hypertension-related cardiovascular changes.
  • Effective blood pressure management significantly mitigates adverse cardiovascular remodelling in hypertensive individuals.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
33
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
22
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
25
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127